Ostarine is the closest SARM to currently being accepted in medicine and it is presently in section II clinical trials. Like SARMs generally, MK-2866 targets androgen receptors on a selective foundation and avoids making the varieties of damaging side effects involved with substances like testosterone, human growth hormone, or anabolic https://erick914nrv1.wikimeglio.com/user